8-KFiled Aug 6, 8:00 PM ET

Neonode Inc. Receives Nasdaq Notice Over Sub-$1 Stock Price

$NEON · Neonode Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Neonode Inc. Receives Nasdaq Notice Over Sub-$1 Stock Price

What Happened
Neonode Inc. (Nasdaq: NEON) announced on Aug. 6, 2026 that Nasdaq’s Listing Qualifications staff notified the company it was no longer in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price for its common stock had been below $1.00 for the previous 30 consecutive business days. The notice does not affect current trading; the company has been given a 180-calendar-day compliance period ending Feb. 2, 2027 to regain compliance by achieving a closing bid of at least $1.00 per share for a minimum of ten consecutive business days.

Key Details

  • Notification date: August 6, 2026; noncompliance due to closing bid < $1.00 for 30 consecutive business days.
  • Compliance cure period: 180 calendar days (until February 2, 2027). Cure requires $1.00+ closing bid for 10 consecutive business days.
  • Possible second period: Company may be eligible for an additional 180-day period if it meets Nasdaq’s market value of publicly held shares and other initial listing standards (except the bid-price test) and notifies Nasdaq of intent to cure (e.g., via a reverse stock split).
  • Current status: Common stock continues to trade on the Nasdaq Capital Market under the symbol “NEON”; company may appeal any delisting determination to a Nasdaq Hearings Panel.

Why It Matters
This notice signals a formal risk of delisting if Neonode cannot lift its share price above the $1 threshold within the specified period. Delisting or prolonged noncompliance can reduce liquidity, limit investor access, and negatively affect shareholder value. The company says it will monitor the situation and consider available options (including a possible reverse stock split and appeal rights), but there is no assurance it will regain compliance. The filing also includes customary forward‑looking statement caution and refers investors to its 2025 Form 10-K for risk factors.